Clinical Trials on Gastroesophageal Reflux Disease (GERD) in Hong Kong
Total 169 results
-
Chinese University of Hong KongRecruitingGastro Esophageal RefluxHong Kong
-
Chinese University of Hong KongUnknownGastroesophageal Reflux DiseaseHong Kong
-
MuhammadNot yet recruitingGastroesophageal Reflux DiseaseHong Kong
-
Chinese University of Hong KongCompletedGastroesophageal Reflux DiseaseChina
-
Chinese University of Hong KongCompletedFunctional Dyspepsia | Irritable Bowel Syndrome | Non-erosive Gastroesophageal Reflux DiseaseHong Kong
-
Chinese University of Hong KongRecruitingObesity | Gastro Esophageal Reflux DiseaseChina
-
Chinese University of Hong KongUnknownGastro-esophageal Reflux DiseaseHong Kong
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongCompletedGastroesophageal Reflux DiseaseChina
-
Hospital Authority, Hong KongThe University of Hong KongUnknown
-
Hospital Authority, Hong KongThe University of Hong KongUnknown
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongRecruitingGastroesophageal RefluxHong Kong
-
Hospital Authority, Hong KongThe University of Hong KongCompletedGastroesophageal Reflux | LaryngitisChina
-
Chinese University of Hong KongTerminated
-
Chinese University of Hong KongCompletedDyspepsia | Gastroesophageal Reflux | Peptic Ulcer Disease | Pancreatobiliary Disease | Ugi MalignanciesHong Kong
-
NovoCure GmbHZai Lab (Shanghai) Co., Ltd.UnknownGastric Cancer | GastroEsophageal CancerHong Kong
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongRecruiting
-
TakedaCompletedGastroesophageal Reflux DiseaseHong Kong, Korea, Republic of, Taiwan
-
AstraZenecaCompletedGastroesophageal Reflux DiseaseVietnam
-
Chinese University of Hong KongCompletedAcral Lentiginous MelanomaHong Kong
-
The University of Hong KongRecruitingRecurrent Glioblastoma | Recurrent Glioma | Poly ADP Ribose Polymerase (PARP) Inhibitor | PTEN Gene Inactivation | IDH MutationHong Kong
-
Hong Kong Children's HospitalThe University of Hong KongRecruiting
-
Arbele Pty LtdRecruitingGastric Cancer | Pancreatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Gastrointestinal Cancer | Liver Cancer | Colorectal Adenocarcinoma | Gastroesophageal JunctionHong Kong, Australia
-
Center Trials & TreatmentWithdrawnGliosarcoma | Recurrent Glioblastoma | Anaplastic GliomasSingapore, Hong Kong
-
Y-mAbs TherapeuticsTerminatedNeuroblastoma RecurrentKorea, Republic of, Hong Kong
-
Janssen Research & Development, LLCEisai Inc.CompletedGastroesophageal Reflux Disease (GERD)United States, Poland, United Kingdom, Belgium, Brazil
-
VA Office of Research and DevelopmentCompleted
-
Center Trials & TreatmentNo longer availableGlioblastoma Multiforme | Melanoma (Skin) | Melanoma Recurrent | Glioma of Brain | Glioblastoma by Gene Expression ProfileHong Kong, Belarus, Tajikistan, Uzbekistan
-
TakedaCompletedGastroesophageal Reflux Disease (GERD)United Kingdom, Australia, Belgium, Spain, Austria, Germany, Argentina, Brazil, Canada, France, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Mexico, Poland, Portugal, Singapore, South Africa, Switzerland, Taiwan
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersTaiwan, Hong Kong, Japan
-
Y-mAbs TherapeuticsWithdrawnNeuroblastomaKorea, Republic of, Singapore, Hong Kong, Russian Federation
-
TakedaCompletedGastroesophageal Reflux Disease | HeartburnChina
-
Braintree LaboratoriesActive, not recruitingNon-erosive Reflux DiseaseUnited States
-
AstraZenecaCompleted
-
TakedaCompletedGastroesophageal Reflux DiseaseUnited States
-
AstraZenecaCompletedGastroesophageal RefluxBulgaria, Italy, South Africa, Spain, Hungary, Canada, Hong Kong, Greece, Germany, Australia, United Kingdom
-
TakedaCompletedGastroesophageal Reflux DiseaseUnited States
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Novartis PharmaceuticalsCompletedMelanoma | CancerTaiwan, Thailand, China, Hong Kong, Korea, Republic of
-
TJ Biopharma Co., Ltd.Active, not recruitingNewly Diagnosed GlioblastomaChina, Hong Kong
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal CancerUnited States, Taiwan, Spain, Germany, Japan, Hong Kong
-
National Cancer Institute (NCI)TerminatedParaganglioma | Metastatic Adrenal Gland Pheochromocytoma | Recurrent Adrenal Gland Pheochromocytoma | Extra-Adrenal ParagangliomaUnited States, Singapore, Hong Kong
-
TakedaCompletedGastroesophageal RefluxUnited States
-
Y-mAbs TherapeuticsRecruitingNeuroblastomaSpain, Denmark, United States, Italy, United Kingdom, Germany, Hong Kong, Canada, France
-
Incheon St.Mary's HospitalNational Cancer Center, KoreaUnknownRecurrent Glioblastoma MultiformeKorea, Republic of
-
Novartis PharmaceuticalsRecruitingCarcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Carcinoma, Ovarian Epithelial | Mesothelioma | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Neoplasms | Anal Cancer | Cutaneous Melanoma | Esophagogastric Cancer | Carcinoma, Thymic | High Microsatellite...Italy, Spain, Singapore, Germany, Taiwan, Japan, Canada, Hong Kong, United States
-
Novartis PharmaceuticalsCompletedNeoplasms | Kidney Neoplasms | Breast Neoplasms | Pancreatic Neuroendocine Neoplasms (pNETs)France, Germany, United States, Netherlands, Italy, Spain, United Kingdom, Hong Kong, Hungary
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Endometrial Carcinoma | Pancreatic CarcinomaUnited States, Germany, Italy, Japan, Belgium, Switzerland, Korea, Republic of, Hong Kong, Finland, France, Spain